Log in to save to my catalogue

Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study

Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_499149

Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study

About this item

Full title

Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study

Publisher

Washington, DC: Endocrine Society

Journal title

The journal of clinical endocrinology and metabolism, 2017-05, Vol.102 (5), p.1661-1672

Language

English

Formats

Publication information

Publisher

Washington, DC: Endocrine Society

More information

Scope and Contents

Contents

Context:Growth hormone (GH) is prescribed for an increasing range of indications, but there has been concern that it might raise cancer risk. Published data are limited.Objective:To examine cancer risks in relation to GH treatment.Design:Cohort study.Setting:Population-based.Patients:Cohort of 23,984 patients treated with recombinant human GH (r-hG...

Alternative Titles

Full title

Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_499149

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_499149

Other Identifiers

ISSN

0021-972X

E-ISSN

1945-7197

DOI

10.1210/jc.2016-2046

How to access this item